Wf. Busby et al., HUMAN CELL MUTAGENICITY OF MONONITROPYRENES AND DINITROPYRENES IN METABOLICALLY COMPETENT MCL-5 CELLS, Mutation research. Genetic toxicology testing, 322(4), 1994, pp. 233-242
Nitropyrenes are ubiquitous environmental pollutants that may pose a h
uman health hazard because some are highly potent mutagens and carcino
gens. The mutagenicity (trifluorothymidine resistance at the thymidine
kinase locus) of 1-, 2-, and 4-nitropyrene (1-, 2-, and 4-NP), 1,3-,
1,6-, and 1,8-dinitropyrene (1,3-, 1,6-, and 1,8-DNP), and pyrene was
assessed in a quantitative forward mutation assay using a metabolicall
y competent line (MCL-5) of human B-lymphoblastoid cells. These cells
contain endogenous cytochrome P450 activity (CYP1A1) and two plasmids
that express cDNAs for four additional P450s (CYP1A2, CYP2A6, CYP2E1,
CYP3A4) and microsomal epoxide hydrolase found in human liver. The maj
or finding is that 2-NP and 1,3-DNP, both potent bacterial mutagens, w
ere nonmutagenic in this assay. The following mutagenic potency series
, expressed as the minimum detectable mutagen concentration (MDMC) in
nmol/ml, was obtained: 1,6-DNP (0.8), 1,8-DNP (1.5), 4-NP (3.1), 1-NP
(9.1), 2-NP (> 81), 1,3-DNP (> 86), pyrene (> 494). There was over an
ii-fold difference between the most potent (1,6-DNP) and the least pot
ent (1-NP) mutagen. 1,6-DNP was approximately twice as mutagenic as 1,
8-DNP, which was almost twice as mutagenic as 4-NP, which, in turn was
nearly three times as potent as 1-NP. This is the first report on the
testing of 2-NP and 4-NP for mutagenicity in mammalian cell cultures.
The human cell mutagenicity of these compounds was discussed in terms
of potency series of nitropyrenes obtained from animal carcinogenicit
y experiments and other mammalian cell mutagenicity assays.